ETON
$8.13
Eton Pharmaceutcials
$.53
6.97%
ETON
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.26)
Revenue:  $1.48 Mil
Thursday
Nov 12
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ETON reports earnings?
Beat
Meet
Miss

Where is ETON's stock price going from here?
Up
Flat
Down
Stock chart of ETON
Analysts
Summary of analysts' recommendations for ETON
Score
Grade
Pivots
Resistance
$8.01
$7.86
$7.73

$7.58

Support
$7.45
$7.30
$7.17
Tweet
Growth
Description
Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.